.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Prof. Dr. Mark Brönstrup

Braunschweig / DE

Helmholtz Centre for Infection Research

Vortrag

13.02.2025
12:20 – 12:30 8 Min. 2 Min.
Short Talk
S-1-6
Highly potent quinoxalindiones prevent tissue damage following S. aureus infection by inhibiting hemolysin alpha
Infections at Interfaces

Weitere Beteiligungen

13.02.2025
12:20 – 12:30 8 Min. 2 Min.
Short Talk
S-1-6
Highly potent quinoxalindiones prevent tissue damage following S. aureus infection by inhibiting hemolysin alpha
Infections at Interfaces
13.02.2025
Poster
P-1-58
Small chemical compounds blocking herpes simplex virus assembly
Immune Prevention and Therapy
13.02.2025
Poster
P-1-31
An anti-virulence strategy to treat Salmonella infections: Development of lead compounds targeting the transcriptional regulator HilD
Infections at Interfaces
14.02.2025
Poster
P-2-3
Gamma-pyrone synthetic compounds display broad-spectrum antiviral activity against RNA viruses by targeting mitochondrial metabolism
Tropical and Emerging Infections
14.02.2025
Poster
P-2-95
Fine-tuning preclinical animal models for providing proof-of-concept for targeted click-to-release activated antibacterials
Antimicrobial Resistance
14.02.2025
Poster
P-2-108
From antimotilin antivirulence compounds to intrabacterial targets
Antimicrobial Resistance
14.02.2025
Poster
P-2-52
Developing broad-spectrum antivirals against emerging viral threats: A systematic approach using the antiviral compound testing platform
Tropical and Emerging Infections